Austin Fast on Muck Rack

Austin Fast

Verified
Cincinnati
As seen in: USA Today, MSN, Yahoo Canada, Yahoo News, Yahoo News UK, ABC News, Aol, NPR, PBS NewsHour, Yahoo Finance, Yahoo Finance Canada and
Data @USAToday || Formerly: @NPR, @TB_Times || @Cronkite_ASU & @MiamiUniversity alum || Returned Peace Corps Volunteer || Oreo enthusiast
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Austin

Contact Austin, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

How Merck keeps prices for its blockbuster cancer drug sky high Original

|
By Ken Alltucker , Austin Fast , Sydney P. Freedberg
| USA Today
Ken Alltucker, Austin Fast and Sydney P. Freedberg April 14, 2026, 5:05 a.m. ET Just a few weeks after President Donald Trump’s December promise that prescription drug prices would plummet "fast and furious," Patricia Brown checked into a California clinic for an infusion of Merck & Co.'s blockbuster cancer drug, Keytruda. When the bill arrived, the clinic's charge for a 400 mg dose dominated the page: $162,567.74. Brown, an accomplished cook battling lung cancer, owed about $2,000.
Open in Who Shared View Duplicates (9) Issue with article?

FDA: Novo Nordisk failed to report deaths of weight-loss drug patients Original

|
By Austin Fast 
| USA Today
March 17, 2026, 5:07 a.m. ET The manufacturer of popular weight-loss drugs Ozempic and Wegovy, Novo Nordisk, is taking heat from the federal government for regularly failing to report potential side effects of its GLP-1 medications, including deaths. In a warning letter dated March 5, the Food and Drug Administration cited five cases where patients taking the drugs experienced a stroke, considered suicide or died ‚Äď one of them by suicide ‚Äď all of which Novo Nordisk failed to report properly.
Open in Who Shared View Duplicates (7) Issue with article?

FDA: Novo Nordisk failed to report deaths of weight-loss drug patients

|
By Austin Fast 
| Detroit Free Press
March 17, 2026, 5:07 a.m. ET The manufacturer of popular weight-loss drugs Ozempic and Wegovy, Novo Nordisk, is taking heat from the federal government for regularly failing to report potential side effects of its GLP-1 medications, including deaths. In a warning letter dated March 5, the Food and Drug Administration cited five cases where patients taking the drugs experienced a stroke, considered suicide or died – one of them by suicide – all of which Novo Nordisk failed to report properly.
Open in Who Shared Issue with article?
See all 1,435 licensed articles (2,208 Total)

Actions

Share this page

Get in touch with Austin

Contact Austin, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified